Who Owns Alnylam Pharmaceuticals Stock?
NASDAQ: ALNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 105.59%
- Institutions (% of float)
- 105.80%
- Held by insiders
- 0.20%
- Institutional holders
- 1,133
- Institutions 99.8%
- Insiders 0.2%
- Public and other 0.0%
Who owns Alnylam Pharmaceuticals stock?
Institutional investors own about 105.6% of Alnylam Pharmaceuticals's shares, spread across 1,133 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.20% of ALNY.
The largest institutional holders are Capital World Investors (10.32%), FMR, LLC (9.42%) and Blackrock Inc. (8.23%). Together, the top 10 institutions control 62.8% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ALNY positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALNY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Capital World Investors | 13.82M | 10.32% | +24.0% |
| FMR, LLC | 12.62M | 9.42% | -16.0% |
| Blackrock Inc. | 11.02M | 8.23% | +1.0% |
| Capital Research Global Investors | 10.94M | 8.17% | +12.2% |
| T. Rowe Price Investment Management, Inc. | 10.01M | 7.47% | +77.4% |
| Vanguard Portfolio Management LLC | 6.70M | 5.00% | +2.4% |
| Vanguard Capital Management LLC | 6.02M | 4.49% | -0.2% |
| BAILLIE GIFFORD & CO | 5.49M | 4.10% | +125.1% |
| State Street Corporation | 3.82M | 2.85% | +7.4% |
| Invesco Ltd. | 3.74M | 2.79% | -0.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALNY
| Fund | Shares | % Held |
|---|---|---|
| Growth Fund of America | 8.96M | 6.69% |
| Amcap Fund | 4.53M | 3.38% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.24M | 3.16% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.89M | 2.16% |
| Invesco QQQ Trust, Series 1 | 2.79M | 2.09% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.14M | 1.60% |
| Fidelity Securities Fund-Fidelity OTC Portfolio | 2.06M | 1.54% |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.03M | 1.52% |
| AMERICAN BALANCED FUND | 1.80M | 1.34% |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 1.62M | 1.21% |
Frequently asked questions
Who is the largest shareholder of Alnylam Pharmaceuticals?
Capital World Investors is the largest institutional shareholder of ALNY, owning 10.32% of shares outstanding (13.82M shares) as of its latest 13F filing.
What percentage of Alnylam Pharmaceuticals is owned by institutions?
Institutions own about 105.6% of ALNY shares and 105.8% of the public float.
How much of Alnylam Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.20% of ALNY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.